Istituto di Ricerca Neuroftalmologia S.r.l. Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2015
NCT04020705
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Istituto di Ricerca Neuroftalmologia S.r.l.

Active Ingredients

Drugs in Other Trials (2)

citicoline (1 trial)

hypromelloses (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 2